The trademark application ORUKA was filed by Oruka Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on September 3, 2024, and still open for oppositions.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with Biochemicals and antibodies for in vitro scientific or research use.
The mark was filed in class 5 with Biologics, antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications.
The mark was filed in class 42 with Biotechnology research related to antibodies and therapies for treatment of chronic skin diseases such as plaque psoriasis, psoriatic arthritis, and other dermatologic and inflammatory indications.